Anzeige
Mehr »
Mittwoch, 20.05.2026 - Börsentäglich über 12.000 News
Bewertet mit 8$ - Preis:139$: Peer-Übernahmen brachten Anlegern dreistellige Gewinne
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Contract Pharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
19:42Scinai Biopharma Services Names Eilon Elmalem Head of Yavne CDMO Site
18:42Pinnaql Acquires Pharma Resource Group, Expanding Core Service Area Depth
17:42Amgen CFO Transition as Peter Griffith Retires, Thomas Dittrich Returns
17:42Samsung Bioepis Launches Ustekinumab Biosimilar in Japan
16:42Oxford Nanopore and Lonza Launch mRNA QC Solution for GMP Testing
15:42Curia Upgrades Aseptic Suites in Valladolid, Spain
15:42BMS to Deploy Claude Agentic AI Across 30,000 Employees
15:42Fujifilm Cellular Dynamics Opens New Headquarters & iPSC Manufacturing Facility in Madison
DiPasskey Therapeutics Taps Mandeep Kaur as Chief Medical Officer
DiCosette Pharmaceuticals Names David Bell CCO of Brands
DiIncyte to Deploy Edison Scientific's AI Scientist Kosmos for R&D
DiATB Therapeutics Names Mark Throsby as CEO
DiVistagen Taps Dr. Angel Angelov as Chief Medical Officer
DiHansa Biopharma Signs IDEFIRIX Licensing Deal With SERB
DiHelio Genomics Partners with Syneos Health to Drive Awareness & Adoption of HelioLiver
MoAstraZeneca Hypertension Treatment Baxfendy Approved by FDA
MoOrca Bio Taps Bijan Nejadnik as New Chief Medical Officer
MoNeurocrine Biosciences Acquires Soleno Therapeutics for $2.9B
MoAstraZeneca, Daiichi Sankyo's Enhertu Gets New US Approval for Two HER2-Positive Breast Cancer Indications
MoProtaGene Teams With MilliporeSigma on End-to-End Testing
MoTriana Biomedicines Taps Dr. Mohan Bala as Chief Operating Officer
MoPiramal Pharma Solutions, Botanix Partner to Support Drug Substance Development
MoFDA Approves First Simponi Biosimilars in U.S.
MoParabilis Medicines, Regeneron Partner to Advance Novel Antibody-Helicon Conjugates
FrVeracyte Gains Medicare Coverage for Muscle-Invasive Bladder Cancer Recurrence Monitoring Test